Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(44 sites)

China

Jiangmen Central Hospital, Jiangmen, Guangdong

Nanyang First People's Hospital, Nanyang, Henan

Beijing Friendship Hospital, Beijing

China-Japan Friendship hospital, Beijing

Peking University People's Hospital, Beijing